Which antibiotic is most likely to interact with warfarin: amoxicillin, azithromycin, cephalexin (Keflex), or trimethoprim‑sulfamethoxazole (Bactrim DS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Bactrim DS (Trimethoprim-Sulfamethoxazole) Has the Highest Risk of Drug Interaction with Warfarin

Among the four antibiotics listed, Bactrim DS (trimethoprim-sulfamethoxazole) poses the most significant drug interaction risk with warfarin, nearly doubling the risk of serious bleeding compared to warfarin alone. 1

Mechanism and Clinical Evidence

Trimethoprim-sulfamethoxazole (TMP-SMX) is a potent CYP2C9 inhibitor, which directly interferes with the metabolism of warfarin's more potent S-enantiomer. This pharmacokinetic interaction is compounded by the fact that all antibiotics can deplete gut microbiome-derived vitamin K, further potentiating warfarin's anticoagulant effects 1.

The clinical significance is well-established:

  • Large national insurance database analyses confirm that TMP-SMX nearly doubles the risk of serious bleeding when combined with warfarin 1
  • Pre-emptive warfarin dose reduction of 25% is recommended when TMP-SMX is co-administered 1
  • In a veterans cohort study, TMP-SMX showed a hazard ratio of 2.09 (95% CI: 1.45-3.02) for serious bleeding events 2

Comparative Risk Profile of the Other Antibiotics

Azithromycin (Moderate Risk)

  • The FDA label acknowledges that spontaneous post-marketing reports suggest azithromycin may potentiate oral anticoagulants, though a controlled study of 22 healthy men showed no effect on prothrombin time 3
  • Veterans cohort data showed azithromycin increased bleeding risk (HR 1.93 for primary bleeding diagnosis; HR 1.64 for serious bleeding) 2
  • However, this risk is substantially lower than TMP-SMX

Amoxicillin (Lower Risk)

  • Amoxicillin showed statistically significant INR increases in older adults 4
  • However, a randomized controlled trial of amoxicillin-clavulanate showed no clinically significant interaction with warfarin in stable patients without infection (mean INR increase 0.22 vs 0.24 with placebo, P=0.94) 5
  • The interaction appears dose-dependent and less clinically significant than TMP-SMX

Cephalexin/Keflex (Lowest Risk)

  • Cephalexin was specifically used as the low-risk control antibiotic in the veterans study 2
  • It does not inhibit CYP450 enzymes
  • While all antibiotics can theoretically affect vitamin K production, cephalexin has the most favorable safety profile when combined with warfarin

Clinical Management Algorithm

When prescribing antibiotics to warfarin patients:

  1. Avoid TMP-SMX if alternatives exist - choose cephalexin when appropriate for the infection
  2. If TMP-SMX is necessary:
    • Reduce warfarin dose by 25% pre-emptively 1
    • Check INR within 3-14 days of co-prescription (this reduces bleeding risk by 39%, HR 0.61) 2
    • Monitor for bleeding symptoms
  3. For azithromycin: Close INR monitoring without routine dose adjustment 3
  4. For amoxicillin or cephalexin: Standard monitoring is generally sufficient

Critical Pitfall to Avoid

The most dangerous scenario occurs when TMP-SMX is initiated in a patient on stable, chronic warfarin therapy. Unlike warfarin initiation (when INR is monitored frequently), adding TMP-SMX to stable warfarin can cause supratherapeutic INR if the interaction goes unrecognized 1. This is when the nearly doubled bleeding risk manifests clinically.

References

1
Guideline

drug interactions affecting oral anticoagulant use.

Circulation: Arrhythmia and Electrophysiology, 2022

4
Research

Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.

The American journal of geriatric pharmacotherapy, 2012

Related Questions

How often should International Normalized Ratio (INR) be monitored in patients taking antibiotics?
Should an elderly patient with buttock cellulitis be treated with intramuscular ceftriaxone and then discharged on trimethoprim‑sulfamethoxazole (Bactrim) and cephalexin (Keflex)?
Do amoxicillin‑clavulanate and azithromycin affect INR in patients taking warfarin?
How does erythromycin interact with warfarin (Coumadin) and what monitoring or dose adjustments are needed?
How should cefalexin (Keflex) be used in a patient on warfarin, and what INR monitoring is required?
What is the appropriate management of a recurrent hemothorax in a 27-year-old female?
How should bedside spirometry be performed and interpreted?
What is Rh immunoglobulin (Rhogam) and how does it help prevent complications after a miscarriage?
Should I start both meropenem (carbapenem) and vancomycin (glycopeptide) now for a 2.8 kg neonate and discontinue ampicillin?
In a neonate with ongoing seizures despite levetiracetam and no clinical response to ampicillin and amikacin, and without blood culture results, what empiric meningitis antibiotic regimen should be initiated?
What advice should be given to a pharmacist without formal immunization training who needs to administer a vaccine to a small, highly resistant child?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.